Operating Lease, Right-of-Use Asset in USD of BioRestorative Therapies, Inc. from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BioRestorative Therapies, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2019 to Q3 2024.
  • BioRestorative Therapies, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $39,697, a 74.3% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BioRestorative Therapies, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $39,697 -$115,029 -74.3% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $78,146 -$105,592 -57.5% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $115,385 -$97,364 -45.8% 31 Mar 2024 10-Q 11 Jun 2024 2024 Q1
Q4 2023 $151,447 -$90,313 -37.4% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q3 2023 $154,726 -$116,046 -42.9% 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $183,738 -$116,045 -38.7% 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 $212,749 -$116,045 -35.3% 31 Mar 2023 10-Q 11 Jun 2024 2024 Q1
Q4 2022 $241,760 -$116,045 -32.4% 31 Dec 2022 10-K/A 11 Jun 2024 2023 FY
Q3 2022 $270,772 -$116,044 -30% 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $299,783 -$116,044 -27.9% 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $328,794 -$116,044 -26.1% 31 Mar 2022 10-Q 12 May 2023 2023 Q1
Q4 2021 $357,805 -$116,044 -24.5% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q3 2021 $386,816 -$116,045 -23.1% 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $415,827 -$116,045 -21.8% 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $444,838 -$116,045 -20.7% 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 $473,849 -$116,045 -19.7% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $502,861 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $531,872 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $560,883 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $589,894 31 Dec 2019 10-K 30 Apr 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.